Phenazine 5,10-dioxide analogues as potential therapeutics in AML: Efficacy on patient-derived blasts, in zebrafish larvae xenografts and synergy with venetoclax
Open Access
- 6 December 2025
- journal article
- Published by Elsevier in Translational Oncology
- Vol. 63, 102628
Abstract
No abstract availableKeywords
Funding Information
- Western Norway Regional Health Authority (F-12533)
- Novo Nordisk Foundation (4462)
- Childhood Cancer Association (230001)
- Childhood Cancer Association (190004)
- Rannís (228683\u2013051)
- The Norwegian Cancer Society (100933)
- NoVo Foundation
- Háskóli Íslands (92252)
This publication has 46 references indexed in Scilit:
- Functionalized regioisomers of the natural product phenazines myxin and iodinin as potent inhibitors of Mycobacterium tuberculosis and human acute myeloid leukemia cellsEuropean Journal of Medicinal Chemistry, 2025
- Liposomes loaded with daunorubicin and an emetine prodrug for improved selective cytotoxicity towards acute myeloid leukaemia cellsInternational Journal of Pharmaceutics, 2024
- Venetoclax in adult acute myeloid leukemiaBiomedicine & Pharmacotherapy, 2023
- A liposomal formulation of simvastatin and doxorubicin for improved cardioprotective and anti-cancer effectInternational Journal of Pharmaceutics, 2022
- Venetoclax-based therapies for acute myeloid leukemiaBest Practice & Research Clinical Haematology, 2019
- Total synthesis and antileukemic evaluations of the phenazine 5,10-dioxide natural products iodinin, myxin and their derivativesBioorganic & Medicinal Chemistry, 2017
- CD34 expression on bone marrow blasts is a novel predictor of poor prognosis independent of FlT3-ITD in acute myeloid leukemia with the NPM1-mutationLeukemia Research, 2013
- A historical perspective on the development of the cytarabine (7 days) and daunorubicin (3 days) treatment regimen for acute myelogenous leukemia: 2013 the 40th anniversary of 7 + 3Blood Cells, Molecules, and Diseases, 2013
- Stress-induced in vitro apoptosis of native human acute myelogenous leukemia (AML) cells shows a wide variation between patients and is associated with low BCL-2:Bax ratio and low levels of heat shock protein 70 and 90Leukemia Research, 2006
- Stages of embryonic development of the zebrafishDevelopmental Dynamics, 1995